English Emily 4
4 · Cartesian Therapeutics, Inc. · Filed Dec 30, 2024
Insider Transaction Report
Form 4
English Emily
Chief Operations Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-12-26−7,650→ 49,369 totalExercise: $3.30Exp: 2031-04-25→ Common Stock (7,650 underlying) - Exercise/Conversion
Common Stock
2024-12-26$3.30/sh+7,650$25,245→ 25,923 total
Footnotes (2)
- [F1]These options are currently exercisable for an additional 35,114 shares of Common Stock and become exercisable for a further 14,255 shares of Common Stock on March 22, 2025.
- [F2]On November 13, 2023, the issuer acquired the private Delaware corporation which was then known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of Common Stock in connection with the merger.